While some counsel that medication like selective serotonin reuptake inhibitors (SSRIs) and anxiolytics (anti-anxiety prescription drugs) could help address cannabis use dysfunction, evidence is lacking as a consequence of tiny study measurements and different ways of examining remedy results.